Summary of the Report of the Joint Commission on Prescription Drug Use, Inc.

  • Marcus M. Reidenberg
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 39)


In 1975, Senator Edward M. Kennedy suggested that the United States needed a better system for monitoring the use and effects of prescription drugs after they were marketed. In 1976, the Joint Commission on Prescription Drug Use was established in the United States by having the 18 Commissioners selected by Senator Kennedy, Chairman, Senate Subcommittee on Health, Dr. Theodore Cooper, Assistant Secretary for Health, and Dr. David Hamburg, President, The Institute of Medicine-National Academy of Sciences from among nominees proposed by the American Academy of Family Physicians, The American Hospital Association, The American Medical Association, the American Pharmaceutical Association, the American Society for Clinical Pharmacology and Therapeutics, the American Society for Pharmacology and Experimental Therapeutics, the American Society of Hospital Pharmacists, the Pharmaceutical Manufacturers Association, and from nominees proposed by representatives of the public at large. Funds for the Commission’s activities were contributed by some of these organizations.


Prescription Drug Joint Commission Hospital Pharmacist Suspected Adverse Drug Reaction American Hospital Association 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science+Business Media New York 1981

Authors and Affiliations

  • Marcus M. Reidenberg
    • 1
  1. 1.Medical CollegeCornell UniversityNew YorkUSA

Personalised recommendations